IARTIntegra LifeSciences Holdings Corporation

$747M

Q3 2018 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$366M+31.2% YoY

Gross Profit

$223M60.8% margin

Operating Income

$24M6.5% margin

Net Income

$13M3.6% margin

EPS (Diluted)

$0.15

QoQ Revenue Growth

-0.1%

Cash Flow

Operating Cash Flow

$79M

Free Cash Flow

$63M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$3.2B

Total Liabilities

$1.4B

Stockholders' Equity

$1.4B

Cash & Equivalents

$206M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$366M	$279M	+31.2%
Gross Profit	$223M	$177M	+25.7%
Operating Income	$24M	$11M	+122.5%
Net Income	$13M	$3M	+320.9%

Revenue Segments

Codman Specialty Surgical

$239M65%

Orthopedics and Tissue Technologies

$127M35%

Geographic Segments

UNITED STATES

$261M71%

Europe

$47M13%

Asia Pacific

$37M10%

Rest Of World

$20M6%

IART Q3 2018 Earnings — Integra LifeSciences Holdings Corporation Revenue & Financial Results | Market Cap Arena